Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy

被引：183

作者：

Westhoff, TH ^{[1
]}

Jochimsen, F ^{[1
]}

Schmittel, A ^{[1
]}

Stöffler-Meilicke, M ^{[1
]}

Schäfer, JH ^{[1
]}

Zidek, W ^{[1
]}

Gerlich, WH ^{[1
]}

Thiel, E ^{[1
]}

机构：

[1] Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 4, D-12200 Berlin, Germany

来源：

BLOOD | 2003年 / 102卷 / 05期

关键词：

D O I：

10.1182/blood-2003-05-1403

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1930 / 1930

页数：1

共 10 条

[1]

Bermúdez A, 2000, HAEMATOLOGICA, V85, P894

[2] Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden:: clinical and molecular evaluation [J].

Colombat, P ;

Salles, G ;

Brousse, N ;

Eftekhari, P ;

Soubeyran, P ;

Delwail, V ;

Deconinck, E ;

Haïoun, C ;

Foussard, C ;

Sebban, C ;

Stamatoullas, A ;

Milpied, N ;

Boué, F ;

Taillan, B ;

Lederlin, P ;

Najman, A ;

Thièblemont, C ;

Montestruc, F ;

Mathieu-Boué, A ;

Benzohra, A ;

Solal-Céligny, P .

BLOOD, 2001, 97 (01) :101-106

[3] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].

Czuczman, MS ;

Grillo-López, AJ ;

White, CA ;

Saleh, M ;

Gordon, L ;

LoBuglio, AF ;

Jonas, C ;

Klippenstein, D ;

Dallaire, B ;

Varns, C .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276

[4] Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. [J].

Dervite, I ;

Hober, D ;

Morel, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :68-69

[5] Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection [J].

Nainan, OV ;

Khristova, ML ;

Bytm, K ;

Xia, GL ;

Taylor, PE ;

Stevens, CE ;

Margolis, HS .

JOURNAL OF MEDICAL VIROLOGY, 2002, 68 (03) :319-327

[6] The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response [J].

Rehermann, B ;

Ferrari, C ;

Pasquinelli, C ;

Chisari, FV .

NATURE MEDICINE, 1996, 2 (10) :1104-1108

[7] Universal primers for real-time amplification of DNA from all known Orthohepadnavirus species [J].

Schaefer, S ;

Glebe, D ;

Wend, UC ;

Oyunbileg, J ;

Gerlich, WH .

JOURNAL OF CLINICAL VIROLOGY, 2003, 27 (01) :30-37

[8] Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab [J].

Sharma, VR ;

Fleming, DR ;

Slone, SP .

BLOOD, 2000, 96 (03) :1184-1186

[9] Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP:: a diagnostic and therapeutic challenge [J].

Skrabs, C ;

Müller, C ;

Agis, H ;

Mannhalter, C ;

Jäger, U .

LEUKEMIA, 2002, 16 (09) :1884-1886

[10] Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. [J].

Suzan, F ;

Ammor, M ;

Ribrag, V .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :1000-1000

← 1 →